FAQ: Intellego Technologies

The board has taken numerous actions, addressing both the acute situation and longer term perspectives. The most important are:
to remove Claes Lindahl as CEO, appoint board member Jacob Laurin as acting CEO, and initiated a new CEO search.
to engage with the KPMG Forensic unit to initiate an independent forensic investigation of the Company’s affairs, using remarks received from NASDAQ as the foundation.
to initiate the process of recovering repayment from Claes Lindahl of the bonus that was paid on November 11 and 12, 2025 
to provide assurances and information to the Company’s key customers, and ask them to participate in ongoing investigations if requested – the purpose has been to preserve valuable customer relationships and lay the groundwork for continued collaboration.
to conduct a comprehensive review of the company’s business strategy, guided by a focus on core operations, cost control, organizational structure and management functions. The review is looking at achieving sales growth in all markets of our core dosimeter products while developing new offerings in collaboration with other UV disinfection industry actors.
to assess our subsidiary Daro and its future in the Intellego group and ways to grow its business beyond the UK and into new areas of UV technology.
to review our UV equipment business to get a better understanding of its strategic value and how best to take it forward.
Update from Intellego – Intellego Technologies

It is the firm view of the Board that Intellego has a viable business that can deliver significant value to shareholders. We have held discussions with customers and other market participants who confirm that in their view Intellego’s technology and products are market-leading and have the potential to dominate the emergent UV disinfection sector in healthcare. Several of these customers look to Intellego for leadership in this specialized niche market.

On December 30 our partner HAI Solutions (HAIS) got an FDA approval for the product QIKCAP in the US market. QIKCAP is based on HAI Solutions’ patented technology, in which Intellego’s photochromic indicator technology constitutes an integrated and essential part of the now approved product. Intellego holds an ownership interest of approximately 10.5 percent in HAIS and, in addition, has exclusive rights to sell QIKCAP in the Chinese market. Intellego is also entitled to license revenues from global sales of the product.

Intellego’s partner HAI Solutions has received FDA approval for QIKcap – Intellego Technologies

The board’s first priority is to secure shareholder value. The board is in constant dialogue with the company’s employees and partners to secure all business obligations and key customer relations. We are also dealing with a series of legal processes in the wake of the EBM investigation.The board’s aim is to be able to present a viable business to the shareholders well before the AGM in the Spring.

Based on what we know, our view is that Intellego’s financial position is stable. At this time, we are evaluating our anticipated cash flow from operations to get an accurate view of future cash receipts. This evaluation also covers previously recognized revenues to determine, in the light of the evidence now coming to light, whether our financial statements need to be restated or write-downs instituted. Our aim is to complete this activity in conjunction with the Q4 report towards the end of February.

KPMG is carrying out an independent forensic investigation into all Company activities that could be the basis for the allegations made by the Swedish Economic Crime Authority (“EBM”). The starting point for the investigation is the remarks received from NASDAQ on 21 November. Although the investigation is paid for by the Company, the Company has assured KPMG of the independence of their investigation and that their conclusions will be made public. The Company has maintained regular contact with KPMG to answer questions and provide new information as it is uncovered. We foresee that this work will be completed at the start of 2026.
Intellego engages KPMG for independent investigation – Intellego Technologies

Nasdaq’s disciplinary committee is in the process of deciding whether the Intellego stock will be delisted. In the interest of the shareholders, the Board has asked Nasdaq that trading in the Intellego share remains halted to enable a reset of the company’s viable business.

The board estimates that it will take at least two months for Intellego to be able to comply with all listing requirements. The board is exploring alternatives in case the share is delisted from Nasdaq.

FI beslutar att handelsstoppet i Intellego ska kvarstå | Finansinspektionen

The Chairman has initiated the nomination process to the AGM. Shareholders are encouraged to bring their suggestions to the Nomination Committee as soon as possible so that new Directors can be elected either at an extraordinary general meeting or at the AGM in the Spring. The company seeks at least two new, independent directors.

Yes. Johan Möllerström will, for the duration of the investigation, refrain from participating in decision-making as a member of the Board of Directors of Intellego. The Board will ensure that Intellego’s operations and corporate governance are maintained throughout the investigation period.
Intellego Technologies’ board member Johan Möllerström has been notified of suspicion of gross fraud – Intellego Technologies

Based on KPMG’s report, and in dialogue with the auditor Deloitte, the board will decide on next steps in the ongoing legal and regulatory processes, including restatement of the company’s financial reporting. We expect to be able to present revised financial reports no later than in connection with the year-end report on 27 February 2026.

It is evident that SEK/EKN have reason to believe that Intellego’s former CEO has acted fraudulently. Due to the confidentiality of the ongoing preliminary investigation, SEK and EKN have not provided further details on the matter.
Polisanmälan mot Intellego av EKN och SEK – EKN/

Deloitte says that as part of the ongoing audit for the financial year 2025, they have found suspicion of accounting fraud which the auditor is obliged to report to the prosecutor. The Board of Intellego welcomes the report from Deloitte, and the contributions it gives to the ongoing legal proceedings headed by Ekobrottsmyndigheten.
Deloitte AB intends to submit a report of suspicion of accounting fraud – Intellego Technologies